NCT06502821 Preferences of Israeli New Physiotherapists in Choosing Their Future Workplace
| NCT ID | NCT06502821 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Haifa |
| Condition | Workplace |
| Study Type | OBSERVATIONAL |
| Enrollment | 500 participants |
| Start Date | 2024-09-15 |
| Primary Completion | 2025-07-15 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 500 participants in total. It began in 2024-09-15 with a primary completion date of 2025-07-15.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study aim to create a multidimensional body of knowledge on the factors influencing physiotherapy graduates in Israel in choosing a workplace, satisfaction with the chosen framework, and intergenerational differences in these factors. In addition, to examine the relationship between the factors for choosing a professional career in physiotherapy and choosing a workplace
Eligibility Criteria
Inclusion Criteria: * physiotherapists Exclusion Criteria: \-
Contact & Investigator
Gali Dar, Prof.
PRINCIPAL INVESTIGATOR
University of Haifa
Frequently Asked Questions
Who can join the NCT06502821 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Workplace. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06502821 currently recruiting?
Yes, NCT06502821 is actively recruiting participants. Contact the research team at galidar@yahoo.com for enrollment information.
Where is the NCT06502821 trial being conducted?
This trial is being conducted at Haifa, Israel.
Who is sponsoring the NCT06502821 clinical trial?
NCT06502821 is sponsored by University of Haifa. The principal investigator is Gali Dar, Prof. at University of Haifa. The trial plans to enroll 500 participants.